Metformin is the most prescribed oral antidiabetic agent for individuals with type 2 diabetes (T2D) due to its relative safety, low cost, and multiple beneficial effects on blood glucose, insulin sensitivity, lipid metabolism, cardiovascular mortality and tumorigenesis (Wu et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.